COVID-19 Update
Mon, 18 Jan 2021 00:00:00 -0500
Italiano
Mon, 18 Jan 2021 00:00:00 -0500
Mon, 11 Jan 2021 00:00:00 -0500
Boston Scientific Corporation (NYSE: BSX) has announced it has initiated a global, voluntary recall of all unused inventory of the LOTUS Edge™ Aortic Valve System due to complexities associated with the product delivery system. The voluntary recall is related solely to the delivery system, as the va
Laboratories should expect some false negative results because the SARS-CoV-2 virus can mutate over time and not be detected.
Fresenius Kabi USA is voluntarily recalling a single lot of Ketorolac Tromethamine Injection, USP, 30 mg/mL, 1 mL fill in a 2 mL amber vial to the user level due to the presence of particulate matter. Particulate matter was found in reserve sample vials. No adverse event reports have been received
80.211.154.110